Wednesday, February 20, 2013

A Washington Post article on Big Pharma

'As drug industry influence over research grows, so does the potential for bias' via Dean Baker's post 'Washington Post gets award for reporting on corrupt pharma practices"
"Academics have “contributed to the quality, intellectual rigor, and impact of . . . clinical trials,” the editors of the nation’s top medical journals, including NEJM, wrote in an editorial in 2001. “But, as economic pressures mount, this may be a thing of the past.”
With the for-profit companies competing to run the trials, “corporate sponsors have been able to dictate the terms,” the editorial said."

No comments: